These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34943986)

  • 21. Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs.
    Schulze M; Sommer A; Plötz S; Farrell M; Winner B; Grosch J; Winkler J; Riemenschneider MJ
    Acta Neuropathol Commun; 2018 Jul; 6(1):58. PubMed ID: 29986767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iPS cells in the study of PD molecular pathogenesis.
    Cobb MM; Ravisankar A; Skibinski G; Finkbeiner S
    Cell Tissue Res; 2018 Jul; 373(1):61-77. PubMed ID: 29234887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells: a tool for modeling Parkinson's disease.
    Bose A; Petsko GA; Studer L
    Trends Neurosci; 2022 Aug; 45(8):608-620. PubMed ID: 35667922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
    Singh Dolt K; Hammachi F; Kunath T
    Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells.
    Oliveira LM; Falomir-Lockhart LJ; Botelho MG; Lin KH; Wales P; Koch JC; Gerhardt E; Taschenberger H; Outeiro TF; Lingor P; Schüle B; Arndt-Jovin DJ; Jovin TM
    Cell Death Dis; 2015 Nov; 6(11):e1994. PubMed ID: 26610207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
    Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
    Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance in monozygotic Parkinson's disease twins - continuum or dichotomy?
    Balck A; Borsche M; Kasten M; Lohmann K; Seibler P; Brüggemann N; Klein C
    Ann Clin Transl Neurol; 2019 Jun; 6(6):1102-1105. PubMed ID: 31211174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
    Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
    Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
    Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease.
    Novak G; Kyriakis D; Grzyb K; Bernini M; Rodius S; Dittmar G; Finkbeiner S; Skupin A
    Commun Biol; 2022 Jan; 5(1):49. PubMed ID: 35027645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
    Zygogianni O; Kouroupi G; Taoufik E; Matsas R
    Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach.
    George G; Singh S; Lokappa SB; Varkey J
    Genomics; 2019 Jul; 111(4):819-830. PubMed ID: 29852216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
    Playne R; Connor B
    Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decoding Parkinson's disease - iPSC-derived models in the OMICs era.
    Krach F; Bogiongko ME; Winner B
    Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
    Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
    Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State.
    Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V
    Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.